Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiac Allograft Vasculopathy: later-stage trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Cardiac Allograft Vasculopathy: 4 US clinical trials tracked, none currently recruiting.
Cardiac Allograft Vasculopathy is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Columbia University, running 1 of these trials.
Enrollment posture brief
Registry condition cardiac-allograft-vasculopathy
OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Cardiac Allograft Vasculopathy has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiac Allograft Vasculopathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiac Allograft Vasculopathy is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
Boston Children's Hospital
NCT02082821
Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
Stanford University
NCT01078363
Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
Columbia University
NCT01403142
Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy
Mayo Clinic
NCT02880137
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiac Allograft Vasculopathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiac Allograft Vasculopathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiac Allograft Vasculopathy page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Cardiac Allograft Vasculopathy trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Columbia University sponsors the most Cardiac Allograft Vasculopathy trials on record, review their full trial history before evaluating a specific study. See Columbia University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiac Allograft Vasculopathy condition card totals 4 registered trials; most-linked intervention ramipril; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.